Clinical radiosensitivity in breast cancer patients carrying pathogenic ATM gene mutations: No observation of increased radiation-induced acute or late effects

Radiotherapy and Oncology

Volumn 69, Issue 2, 2003, Pages 155-160

  Bremer, Michael ^a   Klöpper, Karin ^a   Yamini, Paria ^a   Bendix Waltes, Regina ^a   Dörk, Thilo ^a   Karstens, Johann H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

A T heterozygosity; Ataxia telangiectasia; Breast cancer; Radiation sensitivity

Indexed keywords

ATM PROTEIN; GENOMIC DNA;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; FOLLOW UP; GENE MUTATION; HETEROZYGOSITY; HUMAN; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RADIATION DERMATITIS; RADIOSENSITIVITY; SCORING SYSTEM; SCREENING; SKIN TOXICITY; SUBCUTANEOUS TISSUE; TREATMENT FAILURE;

EID: 0345107249     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2003.08.004     Document Type: Article

References (33)

1. Andreassen C.N., Alsner J., Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol. 64:2002;131-140.
2. Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 92:1996;130-134.
3. Broeks A., Urbanus J.H., de Knijff P., et al. IVS10-6TG, an ancient ATM germline mutation linked with breast cancer. Hum Mutat. 21:2003;521-528.
4. Chenevix-Trench G., Spurdle A.B., Gatei M., et al. Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst. 94:2002;205-215.
5. Common Toxicity Criteria Version 2.0. CTEP website: http://ctep.info.nih. gov/reporting/ctc.html .
6. Cunliffe P.N., Mann J.R., Cameron A.H., Roberts K.D. Radiosensitivity in ataxia telangiectasia. Br J Radiol. 48:1975;374-376.
7. Denham J.W., Hauer-Jensen M. The radiotherapeutic injury - a complex 'wound'. Radiother Oncol. 63:2002;129-145.
8. Dörk T., Bendix R., Bremer M., et al. Spectrum of ATM gene mutations in a population-based series of breast cancer patients. Cancer Res. 61:2001;7608-7615.
9. FitzGerald M.G., Bean J., Hegde S.R., et al. Heterozygous ATM mutations do not contribute to early onset breast cancer. Nat Genet. 15:1997;307-310.
10. Gatti R.A., Tward A., Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations. Mol Genet Metab. 68:1999;419-423.
11. Gilad S., Khosravi R., Shkedy D., et al. Predominance of null mutations in ataxia-telangiectasia. Hum Mol Genet. 5:1996;433-439.
12. Iannuzzi C.M., Atencio D.P., Green S., Stock R.G., Rosenstein B.S. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. Int J Radiat Oncol Biol Phys. 52:2002;606-613.
13. Inskip H.M., Kinlen L.J., Taylor A.M., Woods C.G., Arlett C.F. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. Br J Cancer. 79:1999;1304-1307.
14. Kastan M., Lim D.S., Kim S.T., Yang D. ATM - a key determinant of multiple cellular responses to irradiation. Acta Oncol. 40:2001;686-688.
15. Lavin M., Shiloh Y. The genetic defect in ataxia telangiectasia. Annu Rev Immunol. 15:1997;177-202.
16. Morgan J.L., Holcomb I.M., Morrissey R.W. Radiation reaction in ataxia telangiectasia. Am J Dis Child. 116:1968;557-558.
17. Neubauer S., Arutyunyan R., Stumm M., et al. Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homo- and heterozygotes as determined by three-colour-FISH chromosome painting. Radiat Res. 157:2002;312-321.
18. Polgar C., Fodor J., Major T., et al. Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects. Strahlenther Onkol. 178:2002;597-606.
19. Ramsay J., Birell G., Lavin M. Breast cancer and radiotherapy in ataxia telangiectasia. Lancet. 347:1996;1627.
20. Late effects on normal tissue consensus conference: LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys. 31:1995;1049-1091.
21. Sandoval N., Platzer M., Rosenthal A., et al. Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet. 8:1999;69-79.
22. Savitsky K., Bar-Shira A., Gilad S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
23. Scott S.P., Bendix R., Chen P., Clark R., Dörk T., Lavin M.F. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc Natl Acad Sci. 99:2002;925-930.
24. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 3:2003;155-168.
25. Speit G., Trenz K., Schütz P., Bendix R., Dörk T. Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia teleangiectasia heterozygote cells. Cytogenet Cell Genet. 91:2000;261-266.
26. Stankovic T., Kidd A.M., Sutcliffe A., et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 62:1998;334-345.
27. Su Y., Swift M. Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations. J Am Med Assoc. 286:2001;2233-2234.
28. Swift M., Morrel D., Massey R.B., Chase C. Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med. 325:1991;1831-1836.
29. Thorstenson Y.R., Roxas A., Kroiss R., et al. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 63:2003;3325-3333.
30. Varghese S., Schmidt-Ullrich R.K., Dritschilo A., Jung M. Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient. Radiat Oncol Investig. 7:1999;231-237.
31. Watts J.A., Morley M., Burdick J.T., et al. Gene expression phenotype in heterozygous carriers of ataxia telangiectasia. Am J Hum Genet. 71:2002;791-800.
32. Weissberg J.B., Huang D.D., Swift M. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. Int J Radiat Oncol Biol Phys. 42:1998;1133-1136.
33. West C.M., Elyan S.A., Berry P., Cowan R., Scott D. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia teleangiectasia (AT) and AT heterozygotes. Int J Radiat Biol. 68:1995;197-203.